Vlado Perkovic's Publications

• Rationale, design, demographics and baseline characteristics of the randomized, controlled, Phase 2b SAPPHIRE study of verinurad plus allopurinol in patients with chronic kidney disease and hyperuricaemia

  Journal articles

  2022

  Nephrology Dialysis Transplantation

• Platform Clinical Trials Within NephrologyInterpreting the Evidence

  Journal articles

  2022

  American Journal of Kidney Diseases

• Increase in BNP in Response to Endothelin-Receptor Antagonist Atrasentan Is Associated With Incident Heart Failure

  Journal articles

  2022

  JACC: Heart Failure

• The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial

  Journal articles

  2022

  Diabetes and Metabolism

• Baseline Characteristics of Subjects in the Once-Weekly (OW) Semaglutide FLOW Kidney Outcomes Trial

  Conference Presentations

  2022

• Interleukin-6 and Cardiovascular Outcomes in Patients with Type 2 Diabetes: A Post Hoc Analysis of CANVAS Trial

  Conference Abstracts

  2022

  DIABETES

• Efficacy and Safety of Daprodustat for Treatment of Anemia of Chronic Kidney Disease in Incident Dialysis Patients: A Randomized Clinical Trial

  Journal articles

  2022

  JAMA Internal Medicine

• Cardiovascular and renal outcomes with canagliflozin in patients with peripheral arterial disease: Data from the CANVAS Program and CREDENCE trial

  Journal articles

  2022

  Diabetes, Obesity and Metabolism

• Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology

  Journal articles

  2022

  Diabetes, Obesity and Metabolism

• BASELINE CHARACTERISTICS OF THE FLOW TRIAL POPULATION: KIDNEY OUTCOMES TRIAL WITH ONCE-WEEKLY SEMAGLUTIDE IN PEOPLE WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE

  Conference Papers

  2022

  NEPHROLOGY DIALYSIS TRANSPLANTATION

• Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial

  Journal articles

  2022

  JAMA - Journal of the American Medical Association

• Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Hyperkalemia in People with Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized, Controlled Trials

  Journal articles

  2022

  Circulation

• FC 123: Baseline Characteristics of the Flow Trial Population: Kidney Outcomes Trial With Once-Weekly Semaglutide in People With Type 2 Diabetes and Chronic Kidney Disease

  Conference Abstracts

  2022

  Nephrology Dialysis Transplantation

• Study design and baseline characteristics of patients on dialysis in the ASCEND-D trial

  Journal articles

  2022

  Nephrology Dialysis Transplantation

• A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation

  Journal articles

  2022

  Frontiers in Cardiovascular Medicine

• Effect of the Glucagon-Like Peptide-1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2 Diabetes: Pooled Analysis of SUSTAIN 6 and LEADER

  Journal articles

  2022

  Circulation

• Association between TNF Receptors and KIM-1 with Kidney Outcomes in Early-Stage Diabetic Kidney Disease

  Journal articles

  2022

  Clinical Journal of the American Society of Nephrology

• Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

  Journal articles

  2022

  American Journal of Kidney Diseases

• Prevalence of chronic kidney disease in Asia: A systematic review and analysis

  Journal articles

  2022

  BMJ Global Health

• Impact of SGLT2 inhibitors on the kidney in people with type 2 diabetes and severely increased albuminuria

  Journal articles

  2022

  Expert Review of Clinical Pharmacology

• Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial

  Journal articles

  2022

  Journal of Diabetes Research

• Availability, coverage, and scope of health information systems for kidney care across world countries and regions

  Journal articles

  2022

  Nephrology Dialysis Transplantation

• A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sibeprenlimab Administered Subcutaneously in Patients With IgA Nephropathy

  Conference Papers

  2022

  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

• A Phase 2b Randomized Controlled Trial of Selonsertib in Moderate to Severe Diabetic Kidney Disease (MOSAIC)

  Conference Papers

  2022

  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

• Effect of Canagliflozin on Markers of Hepatic Steatosis and Fibrosis in Patients With Type 2 Diabetes and CKD

  Conference Papers

  2022

  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

• Gene Polymorphism in Organic Anion Transporters Determine the Long-Term Efficacy and Safety of Atrasentan in Patients With Type 2 Diabetes and CKD

  Conference Papers

  2022

  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY